Literature DB >> 24290354

A germline oncogenic MITF mutation and tumor susceptibility.

Brigitte Bressac-de Paillerets1, Fabienne Lesueur2, Corine Bertolotto3.   

Abstract

MITF (Microphthalmia-associated transcription factor) is a lineage specific transcription factor that plays a critical role in melanocyte homeostasis and whose deregulation has been shown to contribute to melanoma disease. A germline mutation in MITF, impairing SUMOylation and predisposing to cutaneous malignant melanoma, was recently identified. Interestingly, an association of the MITF mutation with coexisting melanoma and renal cell carcinoma was also shown. Collectively, these data suggest that MITF has an important oncogenic function in tumorigenesis of multiple tissues/melanocytes and kidney cells.
Copyright © 2013 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  MITF; Melanoma; Mutation

Mesh:

Substances:

Year:  2013        PMID: 24290354     DOI: 10.1016/j.ejcb.2013.10.002

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  17 in total

Review 1.  Genetic predisposition to kidney cancer.

Authors:  Laura S Schmidt; W Marston Linehan
Journal:  Semin Oncol       Date:  2016-09-22       Impact factor: 4.929

Review 2.  Imaging for Screening and Surveillance of Patients with Hereditary Forms of Renal Cell Carcinoma.

Authors:  Yuval Freifeld; Lakshmi Ananthakrishnan; Vitaly Margulis
Journal:  Curr Urol Rep       Date:  2018-08-16       Impact factor: 3.092

Review 3.  Pathways from senescence to melanoma: focus on MITF sumoylation.

Authors:  J Leclerc; R Ballotti; C Bertolotto
Journal:  Oncogene       Date:  2017-08-21       Impact factor: 9.867

Review 4.  Imaging evaluation of hereditary renal tumors: a pictorial review.

Authors:  Takashi Tanaka; Akira Kawashima; Yohei Marukawa; Takahiro Kitayama; Yoshihisa Masaoka; Katsuhide Kojima; Toshihiro Iguchi; Takao Hiraki; Susumu Kanazawa
Journal:  Jpn J Radiol       Date:  2021-03-23       Impact factor: 2.374

5.  Evaluation of antioxidant and anti-melanogenic activities of different extracts from aerial parts of Nepeta binaludensis Jamzad in murine melanoma B16F10 cells.

Authors:  Zahra Tayarani-Najaran; Maryam Akaberi; Mohsen Vatani; Seyed Ahmad Emami
Journal:  Iran J Basic Med Sci       Date:  2016-06       Impact factor: 2.699

6.  Multigene panel sequencing of established and candidate melanoma susceptibility genes in a large cohort of Dutch non-CDKN2A/CDK4 melanoma families.

Authors:  Thomas P Potjer; Sander Bollen; Anneliese J E M Grimbergen; Remco van Doorn; Nelleke A Gruis; Christi J van Asperen; Frederik J Hes; Nienke van der Stoep
Journal:  Int J Cancer       Date:  2019-01-21       Impact factor: 7.396

7.  Lysosomal acid ceramidase ASAH1 controls the transition between invasive and proliferative phenotype in melanoma cells.

Authors:  Justine Leclerc; David Garandeau; Nathalie Andrieu-Abadie; Corine Bertolotto; Charlotte Pandiani; Céline Gaudel; Karine Bille; Nicolas Nottet; Virginie Garcia; Pascal Colosetti; Sophie Pagnotta; Philippe Bahadoran; Garance Tondeur; Baharia Mograbi; Stéphane Dalle; Julie Caramel; Thierry Levade; Robert Ballotti
Journal:  Oncogene       Date:  2018-09-25       Impact factor: 9.867

8.  Expanding the phenotype of E318K (c.952G > A) MITF germline mutation carriers: case series and review of the literature.

Authors:  Leandro Jonata Carvalho Oliveira; Aline Bobato Lara Gongora; Fabiola Ambrosio Silveira Lima; Felipe Sales Nogueira Amorim Canedo; Carla Vanessa Quirino; Janina Pontes Pisani; Maria Isabel Achatz; Benedito Mauro Rossi
Journal:  Hered Cancer Clin Pract       Date:  2021-07-21       Impact factor: 2.857

9.  SIRT1 promotes proliferation and inhibits the senescence-like phenotype in human melanoma cells.

Authors:  Mickaël Ohanna; Caroline Bonet; Karine Bille; Maryline Allegra; Irwin Davidson; Philippe Bahadoran; Jean-Philippe Lacour; Robert Ballotti; Corine Bertolotto
Journal:  Oncotarget       Date:  2014-04-30

10.  Novel combined variants of WT1 and TET2 in a refractory and recurrent AML patient.

Authors:  Qiang Ma; Yixian Guo; Xiaoxi Lan; Guoxiang Wang; Wanling Sun
Journal:  BMC Med Genomics       Date:  2021-06-13       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.